# Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study

> **NCT05447286** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 9 (actual)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** NYX-783
- **DRUG:** Placebo
- **DRUG:** Oxycodone

## Key facts

- **NCT ID:** NCT05447286
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-15
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05447286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05447286, "Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05447286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*